Colony Group’s Exelixis EXEL Stock Holding History

Colony Group’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$400K	Sell	18,290 -5,500	-23%	-$115K	0.01%	591
2023 Q2	$455K	Hold	23,790	–	–	0.01%	582
2023 Q1	$462K	Buy	23,790 +5,500	+30%	+$95.8K	0.01%	575
2022 Q4	$293K	Hold	18,290	–	–	﹤0.01%	721
2022 Q3	$287K	Buy	+18,290	New	+$353K	0.01%	662
2021 Q3	–	Sell	-138,538	Closed	-$2.52M	–	822
2021 Q2	$2.52M	Sell	138,538 -1,030	-0.7%	-$24K	0.05%	270
2021 Q1	$3.15M	Sell	139,568 -2,094	-1%	-$47.3K	0.07%	241
2020 Q4	$2.84M	Buy	141,662 +3,981	+3%	+$83.3K	0.07%	237
2020 Q3	$3.37M	Sell	137,681 -887	-0.6%	-$20.7K	0.09%	199
2020 Q2	$3.29M	Buy	138,568 +1,987	+1%	+$46K	0.1%	189
2020 Q1	$2.35M	Buy	136,581 +67,361	+97%	+$1.23M	0.08%	218
2019 Q4	$1.22M	Sell	69,220 -60,980	-47%	-$1.03M	0.03%	372
2019 Q3	$2.3M	Buy	130,200 +5,140	+4%	+$104K	0.07%	245
2019 Q2	$2.67M	Buy	+125,060	New	+$2.62M	0.08%	221

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Colony Group's EXEL Position: Q3 2023 in Review

Colony Group reduced its Exelixis (EXEL) stake by 23% in Q3 2023, selling an estimated $115K and leaving 18,290 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #591.

Colony Group first reported a position in EXEL in Q2 2019 and has held it in 14 quarters since. The position peaked at $3.37M in Q3 2020. 398 funds tracked by Wall St. Rank hold EXEL as of Q3 2023.

Colony Group held 18,290 shares of Exelixis worth $400K as of Q3 2023.
Colony Group sold 5,500 Exelixis shares in Q3 2023, an estimated $115K.
Exelixis made up 0.01% of Colony Group's portfolio in Q3 2023, its #591 holding.
Colony Group first reported a position in Exelixis in Q2 2019 and has held it in 14 quarters since.
Colony Group's Exelixis position peaked at $3.37M in Q3 2020.
398 funds tracked by Wall St. Rank held Exelixis as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.